Berto Colón Appointed to Cristian Rivera Foundation Board
The Cristian Rivera Foundation (CRF) is excited to share the news of actor Berto Colón joining its board. His dedication to impactful changes aligns perfectly with their goal of providing support and awareness to families affected by Diffuse Intrinsic Pontine Glioma (DIPG).
Colón's Passion for Change
As the founder, John "Gungie" Rivera, expressed, Colón's commitment to making a positive difference in the community is something that resonates deeply with the foundation's mission. The CRF is enthusiastic about having Colón contribute to efforts aimed at creating significant changes in the search for solutions to DIPG.
Acclaimed Career and Recent Projects
Berto Colón is known for his compelling performances in popular series like Orange is the New Black and The Penguin, alongside his role in Power Book II: Ghost. His recent work on Night Agent Season 2 has gained global acclaim, marking him as a notable figure in entertainment.
Advocacy for Families Affected by DIPG
During his engagement with the foundation, Colón reflected on the commendable efforts made by John Rivera to honor his late son, Cristian. Colón shared his personal connection to Rivera's mission, expressing admiration for the determination exhibited in raising awareness for such a devastating illness that impacts innocent children.
Supporting the Cause
The foundation’s Chairwoman, Melinda Colon Cox, noted the vital need for board members who show unwavering passion for making a difference. Colón, with his drive to promote positive change, exemplifies the ideal candidate for this important role.
An Esteemed Board
Colón steps into a distinguished cohort of actors and public figures on the CRF Board, joining talents such as Kenan Thompson, Luis Guzmán, Malik Yoba, and Darlene Rodriguez, along with A.J. Calloway and MLB player Gio Urshela. This dynamic mix enhances the foundation's voice in advocating for change.
The Cristian Rivera Foundation’s Mission
The Cristian Rivera Foundation was established to eliminate DIPG by supporting research for effective treatments, spreading awareness, and offering support to families. John Rivera's loss of his son to this heartbreaking illness prompted the formation of this 501(c)(3) organization in 2009.
Making Progress in Research
To date, the foundation has allocated more than 3.5 million dollars towards innovative research contributing to prospective treatments for DIPG. Thanks to the foundation's efforts, remarkable progress has been observed, with several children benefiting from clinical trials conducted by Dr. Mark Souweidane at Weill Cornell Medical Center.
Ongoing Support for Affected Families
In addition to funding critical research, the Cristian Rivera Foundation provides essential resources, assisting families in navigating the complexities of coping with the challenges posed by DIPG. This includes emotional support, educational materials, and financial assistance, which are crucial for families on this difficult journey.
Frequently Asked Questions
1. What is the Cristian Rivera Foundation?
The Cristian Rivera Foundation aims to create a world without DIPG by funding research, raising awareness, and supporting affected families.
2. Who is Berto Colón?
Berto Colón is an actor known for his roles in various acclaimed series and is recently appointed to the Cristian Rivera Foundation board.
3. What is DIPG?
Diffuse Intrinsic Pontine Glioma (DIPG) is a rare and aggressive brain tumor primarily affecting children.
4. How does the foundation support families?
CRF provides resources like emotional support, educational materials, and financial assistance to families impacted by DIPG.
5. What progress has been made in DIPG research?
The foundation has contributed significantly to research, with children responding well to clinical trials, offering hope for future treatments.
